SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-063064
Filing Date
2013-12-17
Accepted
2013-12-17 16:00:56
Documents
2
Period of Report
2013-12-16

Document Format Files

Seq Description Document Type Size
1 LOAR INITIAL FILING rrd397557.html 3  
1 LOAR INITIAL FILING rrd397557.xml 3 2100
2 POWER OF ATTORNEY rrd357715_405288.htm EX-24.1 5466
  Complete submission text file 0001181431-13-063064.txt   9030
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 PENOBSCOT DR REDWOOD CITY CA 94063
Business Address
LOAR MATTHEW M (Reporting) CIK: 0001236260 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36066 | Film No.: 131281875